July 28, 2015 4:31 PM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
(NASDAQ: GILD) surged over 2 percent in after-hours trading after the company reported better-than-expected earnings for the second quarter and raised its FY15 sales forecast.The Foster City, California-based company posted quarterly net income of $4.5 billion, or $2.92 per share, up from $3.7 billion, or $2.20 per share, in the year-ago quarter. Excluding items, the company's non-GAAP earnings climbed to $3.15 per share from $2.36 per share.Its total revenue jumped to $8.2 billion from $6.5 billion. However, analysts were expecting earnings of $2.71 per share on revenue of $7.61 billion.Total product sales rose to $8.1 billion for the second quarter, versus $6.4 billion in the year-ago quarter. Product sales in the U.S. gained to $5.6 billion from $4.8 billion, while product sales in Europe rose to $2.0 billion from $1.3 billion.The average estimate among 281 Estimize users was for earnings of $2.78 per share and revenue of $7.55 billion.As of June 30, 2015, the company had $14.7 billion of cash, cash equivalents and marketable securities, versus $14.5 billion as of March 31, 2015.The company's board declared a cash dividend of $0.43 per share of common stock for the third quarter.Gilead now expects FY15 product sales of $29 billion to $30 billion.Gilead Sciences shares gained 2.33 percent to $115.70 in the after-hours trading session.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.